20:21 EDT Cathie Wood’s ARK Investment buys 395K shares of Beam Therapeutics (BEAM) today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics announces U.S. FDA granted RMAT to BEAM-101
- 3 Small-Cap Stocks That Could Double Your Money, According to Analysts
- Beam Therapeutics: Strong Buy Rating Backed by Promising Trials and Solid Financial Position
- Private Markets: Canva draws attention as IPO candidate following Figma debut
- Beam Therapeutics: Promising Advancements in Genetic Medicine with Upcoming Catalysts Justifying Buy Rating